Shareholders meeting

June 22, 2026 To, To, National Stock Exchange of India Ltd BSE Limited Exchange Plaza, BKC P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Notice of the 24th Annual General Meeting of the Company for the Financial Year 2025-26. Dear Sir/Madam, Pursuant to the provisions of Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 24th Annual General Meeting (AGM) of the Company will be held on Friday, July 17, 2026 at 11:00 A.M. IST through Video Conferencing/ Other Audio Visual Means (“VC/ OAVM”). Please find enclosed the copy of the Notice of 24th AGM for the Financial Year 2025-26 of the Company. The Notice of the 24th AGM is also being uploaded on the website of the Company at www.jupiterhospital.com You are requested to kindly take the afore-mentioned on record and oblige. Thanking You, For JUPITER LIFE LINE HOSPITALS LIMITED Suma Upparatti Company Secretary & Compliance Officer Encl: as stated above Jupiter Life Line Hospitals Limited CIN: L85100MH2002PLC137908 Registered Office: 1004, 10th floor, ‘360 Degree Business Park’, LBS Marg, Mulund (W), Mumbai - 400 080 Corporate Office: Jupiter Hospital, Eastern Express Highway, Thane West – 400 601, Maharashtra Website : www.jupiterhospital.com Email: investor.relations@jupiterhospital.com Tel.: +91 022 6297 5623 NOTICE OF THE 24th ANNUAL GENERAL MEETING Notice is hereby given that the Twenty-Fourth 24th Annual “RESOLVED THAT Dr. Ajay Thakker (DIN: 00120887) General Meeting (AGM) of the Members of Jupiter Life who retire by rotation at this Annual General Meeting Line Hospitals Limited (“Company” / “the Company”) pursuant to the provision of Section 152 and other will be held on Friday, 17th July, 2026 at 11.00 A.M. IST applicable provisions of the Companies Act, 2013 through Video Conferencing/ Other Audio-Visual Means be and are hereby reappointed as a Director of the (‘‘VC/OAVM”) to transact the following businesses: - Company.” ORDINARY BUSINESS: SPECIAL BUSINESS: 1) To receive, consider and adopt: 4) T o approve appointment with change in designation and remuneration of Dr. Ajay Thakker (DIN:- the Audited Standalone Financial Statements of the 00120887) as Chairman & Whole Time Director Company for the financial year ended 31st March with effect from 17th July, 2026. 2026 including the reports of the Board of Directors To consider and if thought fit, to pass following and the Auditors thereon. resolution as Special Resolution: - To consider and if thought fit, to pass following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Sections 179, 196, 197, 203 and other applicable “RESOLVED THAT the Audited Standalone Financial provisions, if any, of the Companies Act, 2013, Statements of the Company including the Audited read with Schedule V thereto and the Companies Balance Sheet and Statement of Profit & Loss, the (Appointment and Remuneration of Managerial Cash Flow Statement and the Statement of Changes Personnel) Rules, 2014 (including any statutory in Equity for the financial year ended 31st March, 2026 modification(s) or re-enactment(s) thereof), and other along with notes thereon, and the Auditors Report and applicable provisions of the SEBI (Listing Obligations Report of the Board of Directors thereon along with all and Disclosure Requirements) Regulations, 2015 annexures, be and is hereby received, considered and (“SEBI Listing Regulations”), and subject to such other adopted.” consents, permissions, and approvals as may be 2) To receive, consider and adopt: necessary, the Articles of Association of the Company, the Audited Consolidated Financial Statements and based on the recommendation of the Nomination of the Company for the financial year ended and Remuneration Committee and the Board of 31st March, 2026, including Auditors report thereon. Directors of the Company, the consent of the members of the Company be and is hereby accorded for the To consider and if thought fit, to pass following appointment with change in designation of Dr. Ajay resolution as an Ordinary Resolution: Thakker (DIN: 00120887) from Chairman & Managing “ RESOLVED THAT the Audited Consolidated Financial Director to Chairman & Whole Time Director of the Statements of the Company including the Audited Company, and whose office shall be liable to retire Balance Sheet and Statement of Profit & Loss, the by rotation for a period of 5 (five) years commencing Cash Flow Statement and the Statement of Changes from 17th July, 2026 to 16th July, 2031 (both days in Equity for the financial year ended 31st March, 2026 inclusive) subject to approval of the shareholders of along with notes thereon, and the Auditors Report the Company. along with all annexures, be and is hereby received, RESOLVED FURTHER THAT pursuant to the considered and adopted.” provisions of Sections 196, 197, 198, 200 & 203 read 3) To appoint a director in place of Dr. Ajay Thakker with Schedule V and other applicable provisions, (DIN: 00120887) who retires by rotation and being if any, of the Companies Act, 2013, the Companies eligible, offers himself for re-appointment. (Appointment and Remuneration of Managerial To consider and if thought fit, to pass following Personnel) Rules, 2014 (including any statutory resolution as an Ordinary Resolution: modifications or re-enactment(s) thereof for the time Jupiter Life Line Hospitals Limited 1 being in force) and Regulation 17(6)(e) of the Securities equity share of the Company, such that 1 (one) equity and Exchange Board of India (Listing Obligations and share of face value of ` 10 (Rupees ten only) each, fully Disclosure Requirements) Regulations, 2015, based paid up, be sub-divided into 5 (Five) equity shares of a on the recommendation of the Nomination and face value of ` 2 (Rupee Two Only) each, fully paid up, Remuneration Committee, the Audit Committee and thereby keeping the paid-up share capital intact. the consent of the Board of Directors of the Company, RESOLVED FURTHER THAT pursuant to the sub- subject to the approval of the shareholders, consent division of equity shares of the Company with effect be and is hereby accorded for fixing remuneration from the record date, each equity share of the Company payable to Dr. Ajay Thakker (DIN: 00120887), Chairman having a face value of ` 10 (Rupees Ten Only) in the & Whole Time Director of the Company, at up to ` 75 issued, subscribed and paid- up equity share capital Lakhs per month (which includes professional fees, shall stand sub-divided into 5 (Five) equity shares of a performance-based pay, allowances and perquisites) face value of ` 2 (Rupee Two only) each. and entitled to other benefits such as insurance, RESOLVED FURTHER THAT upon sub-division of the leave and leave encashment as per the policies of the equity shares as aforesaid and as on the record date, Company, for a period of five years effective from 17th any Director or the Company Secretary of the Company July, 2026, with authority vested with the Nomination and/or its Registrar and Share Transfer Agent (“RTA”) and Remuneration Committee of the Board and be and are hereby authorised to give effect to the sub- the Board of Directors to review and determine his division by consolidating, crediting, and maintaining remuneration on a yearly basis. the sub-divided shareholding in compliance with RESOLVED FURTHER THAT Dr. Ajay Thakker shall applicable laws and guidelines. Accordingly, the sub- be entitled to reimbursement of expenses incurred in divided equity shares of face value ` 2 (Rupee Two connection with furthering the business objectives of only) each, fully paid-up, shall be credited to the the Company, such as travelling, boarding and lodging respective beneficiary accounts of the members with expenses, membership of club(s), seminar expenses their depository participants, and the Comp [Showing first 8,000 characters — download PDF for full document]